This ticker has not been starred yet PCSA Processa Pharmaceuticals, Inc.
Pharmaceutical Preparations
Book value per $ invested $ 0.08
Leverage 23.09%
Market Cap $ 77.1m
PE 0.00
Dividend Yield 0.00%
Profit $ -12.9m
Margin -8441.82%

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients with unmet medical needs in the United States. The company is headquartered in Hanover, Maryland.

Subscribe Now For Access - Only $1.99 Per Month